EAACI Congress 2024
BackOAS 16 - Insights into Hereditary Angioedema management
Saturday 01 Jun, 16:45 PM -
18:15 PM Valencia, Spain
Bilbao
Oral Abstract Sessions
16:45
Characteristics of Nailfold Videocapillaroscopy in Hereditary Angioedema due to C1 Inhibitor Deficiency
16:57
A sensitive and specific assay to characterize plasma kallikrein activity in plasma from hereditary angioedema (HAE) patients
17:09
Impact of hereditary angioedema on dental care: from a study of 112 French patients
17:21
Efficacy and Safety of Oral Deucrictibant, a Potent Bradykinin B2 Receptor Antagonist, in Prophylaxis of Hereditary Angioedema Attacks: Results of CHAPTER-1 Phase 2 Trial
17:33
Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients with Hereditary Angioedema
17:45
Health-related quality of life in hereditary angioedema patients using subcutaneous plasma derived C1 inhibitor therapy in Canada
17:57
Real-life features of hereditary angioedema attacks: first results from the registry supported by ITACA (Italian network for hereditary and acquired angioedema)
